The Hidden Costs of Pre-Analytical Errors and How Unified Sample Tracking Solves Them

Pre-analytical errors are usually discussed as a quality problem. They are also a cost problem — and one that rarely appears as a single line in a budget. A rejected sample looks free because no one writes a cheque for it. But every rejection, redraw and delayed result consumes staff time, reagents and capacity, and pushes cost downstream into the rest of the health system.

This article breaks down where the money actually goes, so laboratory leaders can make the case for prevention. For the underlying error types and why they happen, see the pre-analytical errors pillar and why the phase is so complex.

Direct Costs: The Part You Can Count

The most visible cost is the rejected sample. Published meta-analyses put specimen rejection at roughly 2% of samples on average, with hemolysis, clotting, insufficient volume and labelling problems as the leading reasons. Each rejection triggers a fairly predictable chain of direct costs:

• The wasted tube, consumables and any reagents already used.
• Staff time to identify, document and communicate the rejection.
• A recollection — another phlebotomy visit, another tube, another trip through the workflow.
• Re-processing and re-analysis of the replacement sample.

A single redraw may seem minor, but at a 2% rejection rate across tens of thousands of samples a year, the recollection workload alone is substantial.

Hidden Costs: The Larger, Quieter Half

The direct costs are only the visible tip. The larger burden is indirect and easy to overlook.

Turnaround Time and Capacity

The pre-analytical phase accounts for a large share of total turnaround time. Every rejection or delay resets the clock and consumes capacity that could have processed a first-time-right sample. Slower turnaround has knock-on costs for the clinicians and patients waiting on results.

Staff Time and Rework

Chasing missing information, re-labelling, investigating discrepancies and arranging recollections is skilled-staff time that produces no diagnostic value. In a tight labour market, that rework is one of the most expensive hidden costs a laboratory carries.

Downstream Clinical Cost

A delayed or repeated test can delay a diagnosis or a discharge. The costliest errors are the high-severity ones — a misidentified sample or wrong-blood-in-tube event — because their consequences extend well beyond the laboratory into repeat investigations and patient safety.

Why Fragmented Systems Make It Worse

When collection sites, couriers and the laboratory each use separate, disconnected tools, data is re-entered at every handoff and problems are only discovered late — usually at the bench, after the cost has already been incurred. Fragmentation converts small, cheap-to-prevent errors into large, expensive-to-fix ones.

How Unified Sample Tracking Reduces the Bill

A single, connected record across the whole sample journey attacks each cost bucket:

• Fewer rejections — guided collection and verified identification prevent the technique and labelling errors that drive most rejections.
• Fewer redraws — catching a compromised sample in transit, or confirming it is sound, avoids unnecessary recollection.
• Less rework — automatic capture of identity, time and condition removes the manual chasing and re-entry.
• Faster turnaround — first-time-right samples move through the workflow without resets.
• Targeted improvement — analytics show exactly where errors and their costs concentrate, so investment goes where it pays back.

Choosing the right platform matters; our guide to choosing a laboratory sample tracking system walks through the criteria.

Estimating Your Own Cost

You do not need a formal study to size the problem. A rough estimate uses four numbers you already have or can approximate: annual sample volume, your rejection rate, the average staff time and consumables per rejection/redraw, and the share of results whose turnaround is affected. Multiply them out and the “free” rejected sample turns into a concrete annual figure — usually large enough to justify prevention on its own.

Frequently Asked Questions

What does a rejected sample actually cost?

More than the tube. A rejection consumes consumables and any reagents used, staff time to handle and document it, a recollection visit, and re-processing of the replacement — plus the turnaround-time cost of the delay. Published cost-per-error figures vary widely by setting, so the most reliable estimate is one built from your own volumes and rejection rate.

How common are rejected samples?

Meta-analyses report an average specimen rejection rate of roughly 2%, though this varies by test type and laboratory. Coagulation samples and certain collection settings tend to be higher.

What is the most expensive pre-analytical error?

High-severity identification errors, such as wrong-blood-in-tube, because their downstream consequences — repeat investigation and patient-safety impact — dwarf the direct cost of the sample itself.

How does sample tracking pay for itself?

By reducing rejection and redraw volumes, cutting manual rework, and improving turnaround. The saving scales with sample volume, so higher-throughput laboratories typically see the fastest payback. Estimate it from your own rejection rate and staff-time figures.

Talk to S4DX about quantifying and reducing your pre-analytical cost burden.